Additionally, PD-1 and PD-L1 expression in tumor-infiltrating lymphocytes and tumor cells, respectively, are favorable prognostic markers, correlating with improved clinical outcomes in HPV-associated cancers [79]. This evidence concerns the gene PDCD1 and neoplasm.